1100
D. Shi et al.
LETTER
r.t. When the reaction was completed (at refluxing for 5 h
under N2), most of the solvent was removed in vacuo. The
residue was poured into 10% HCl (100 mL), and extracted
with CHCl3 (3 × 50 mL). The combined organic layers were
washed with water (3 × 50 mL), dried (Na2SO4), and the
solvent was removed in vacuo to give the crude product to
give the pure product 3.
Acknowledgment
We are grateful to the Natural Science Foundation of Jiangsu
Education Committee (03KJB150136) for financial support.
References
(15) The general procedure is represented as follow: A solution of
2-(2-nitrophenyl) imindazole 4 (2 mmol) and ortho-ester 5
(4mmol) in anhyd THF (10 mL) was added carefully at r.t.
to a suspension of low-valent titanium reagent (10 mmol)
prepared as mentioned above. When the reaction was
completed (at r.t. under N2), the reaction mixture was poured
into 10% HCl, and extracted with CHCl3. The combined
organic layers were washed with water, dried (Na2SO4), and
the solvent was removed in vacuo to give the crude product.
The crude product was purified by column chromatography
on silica gel (200–300 mesh) using petroleum ether (bp 60–
90 °C)–acetone (5:1) as eluent.
(1) McMurry, J. E.; Fleming, M. P. J. Am. Chem. Soc. 1974, 96,
4708.
(2) McMurry, J. E.; Miller, D. D. Tetrahedron Lett. 1983, 24,
1885.
(3) Fürstner, A.; Emst, A.; Krause, H.; Ptock, A. Tetrahedron
Lett. 1996, 52, 7329.
(4) Zhou, L. H.; Tu, S. J.; Shi, D. Q.; Dai, G. Y.; Chen, W. X.
Synthesis 1998, 851.
(5) Mariappan, P.; Gadthula, S.; Surisetti, S. Tetrahedron Lett.
2001, 42, 7123.
(6) Shi, D. Q.; Chen, J. X.; Chai, W. Y.; Chen, W. X.; Kao, T.
Y. Tetrahedron Lett. 1993, 34, 2963.
(16) Typical physical data for representative compounds:
Compound 3a: mp 140–141 °C. IR (KBr): 3067, 1600, 1565,
1550, 1470, 1290, 1230, 1160, 920, 800, 735 cm–1. 1H NMR
(400 MHz, CDCl3): 4.92 (s, 2 H, C4-H), 7.01 (d, J = 6.4 Hz,
1 H, C5-H), 7.10 (d, J = 8.8 Hz, 2 H, C2¢-H, C6¢-H), 7.15 (d,
J = 7.6 Hz, 1 H, C8-H), 7.21–7.29 (m, 2 H, C6-H, C7-H), 7.40
(d, J = 8.8 Hz, 2 H, C3¢-H, C5¢-H), 7.56 (s, 1 H, C2-H). Anal.
Calcd for C14H11ClN2: C, 69.29; H, 4.57; N, 11.54. Found:
C, 69.53; H, 4.26; N, 11.72%. Compound 6a: mp 193–195
°C. IR (KBr): 3058, 1603, 1473, 1379, 1353, 1310, 1262,
1235, 894, 778, 746, 704, 693 cm–1. 1H NMR (400 MHz,
CDCl3): 7.30–7.41 (m, 3 H, ArH), 7.53–7.59 (m, 5 H, ArH),
7.70–7.74 (m, 4 H, ArH), 7.86 (d, J = 8.0 Hz, 1 H, ArH), 7.97
(d, J = 7.6 Hz, 1 H, ArH), 8.72 (s, 1 H, ArH). Anal. Calcd for
C22H15N3: C, 82.22; H, 4.70; N, 13.08. Found: C, 82.41; H,
4.46; N, 13.16. Compound 8a: mp 240–241 °C. IR (KBr):
3240, 3012, 2979, 1614, 1512, 1479, 1444, 1367, 1275,
1211, 1161, 1072, 964, 916, 791, 773, 752, 698 cm–1. 1H
NMR (400 MHz, DMSO-d6): 1.36 (s. 6 H, 2 × CH3), 6.52 (s,
1 H, NH), 6.79 (d, J = 8.8 Hz, 1 H, ArH), 6.83 (d, J = 7.2 Hz,
1 H, ArH), 7.08–7.19 (m, 4 H, ArH), 7.36 (d, J = 7.2 Hz, 2
H, ArH), 7.51–7.54 (m, 5 H, ArH), 7.84 (d, J = 7.2 Hz, 1 H,
ArH). Anal. Calcd for C24H21ClN2: C, 82.02; H, 6.02; N,
11.96. Found: C, 82.25; H, 5.89; N, 12.10.
(7) Shi, D. Q.; Mu, L. L.; Lu, Z. S.; Dai, G. Y. Synth. Commun.
1997, 27, 4121.
(8) Zhou, L. H.; Shi, D. Q.; Dai, G. Y.; Chen, W. X.
Tetrahedron Lett. 1997, 38, 2729.
(9) (a) Billimmoria, A. D.; Cava, M. P. J. Org. Chem. 1994, 59,
6772. (b) Blackman, A.; Hambley, T. M.; Picker, R.; Taylor,
W. C.; Thirasana, N. Tetrahedron Lett. 1987, 28, 5561.
(10) (a) Helissey, P.; Cros, S.; Giorgi-Renault, S. Anti-Cancer
Drug Des. 1994, 9, 51. (b) Ibrahim, E.; Montgomerie, A.
M.; Sneddon, A. H.; Proctor, G. R.; Green, B. Eur. J. Med.
Chem. 1988, 23, 183. (c) Riou, J. F.; Helissey, P.; Grondard,
L.; Giorgi-Renault, S. Mol. Pharmacol. 1991, 40, 699.
(d) Brana, M. F.; Castellano, J. M.; Keilhauer, G.; Machuca,
A.; Martin, Y.; Redondo, C.; Schlick, E.; Walker, N. Anti-
Cancer Drug Des. 1994, 9, 527.
(11) Li, J.; Shi, D. Q.; Chen, W. X. Heterocycles 1997, 45, 2381.
(12) Zhou, L. H.; Tu, S. J.; Shi, D. Q.; Dai, G. Y. J. Chem. Res.,
Synop. 1998, 398.
(13) Shi, D. Q.; Rong, L. C.; Wang, J. X.; Zhuang, Q. Y.; Wang,
X. S.; Tu, S. J.; Hu, H. W. J. Chem. Res., Synop. 2003, 342.
(14) The general procedure is represented as follow: TiCl4 (2.2
mL, 20 mmol) was added dropwise using a syringe to a
stirred suspention of zinc dust (2.6 g, 40 mmol) in freshly
distilled anhyd THF (20 mL) at r.t. under anhyd nitrogen
atmosphere. After completion of the addition, the mixture
was refluxed for 2 h. The suspension of the low-valent
titanium reagent formed was cooled to r.t. and a solution of
2-nitrobenzyl amine 1 (5 mmol) and triethyl orthoformate
(2) (10 mmol) in anhyd THF (10 mL) was added carefully at
(17) (a) Shi, D. Q.; Wang, J. X.; Shi, C. L.; Rong, L. C.; Wang,
X. S.; Hu, H. W.; Yu, K. B. Acta Cryst. 2003, E59, o1846.
(b) Shi, D. Q.; Wang, J. X.; Shi, C. L.; Rong, L. C.; Wang,
X. S.; Hu, H. W. Acta Cryst. 2003, E59, o1661.
Synlett 2004, No. 6, 1098–1100 © Thieme Stuttgart · New York